NO178546C - Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning

Info

Publication number
NO178546C
NO178546C NO871282A NO871282A NO178546C NO 178546 C NO178546 C NO 178546C NO 871282 A NO871282 A NO 871282A NO 871282 A NO871282 A NO 871282A NO 178546 C NO178546 C NO 178546C
Authority
NO
Norway
Prior art keywords
preparation
ace inhibitors
therapeutically active
analogous method
nootropic effect
Prior art date
Application number
NO871282A
Other languages
English (en)
Norwegian (no)
Other versions
NO871282D0 (no
NO871282L (no
NO178546B (no
Inventor
Franz Hock
Josef Scholtholt
Hansjorg Urbach
Rainer Henning
Ulrich Lerch
Wolf-Ulrich Nickel
Wolfgang Ruger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO871282D0 publication Critical patent/NO871282D0/no
Publication of NO871282L publication Critical patent/NO871282L/no
Publication of NO178546B publication Critical patent/NO178546B/no
Publication of NO178546C publication Critical patent/NO178546C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Epoxy Compounds (AREA)
  • Indole Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
NO871282A 1986-03-27 1987-03-26 Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning NO178546C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (de) 1986-03-27 1986-03-27 Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen

Publications (4)

Publication Number Publication Date
NO871282D0 NO871282D0 (no) 1987-03-26
NO871282L NO871282L (no) 1987-09-28
NO178546B NO178546B (no) 1996-01-08
NO178546C true NO178546C (no) 1996-04-17

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871282A NO178546C (no) 1986-03-27 1987-03-26 Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning

Country Status (25)

Country Link
EP (1) EP0243645B1 (cs)
JP (1) JPS62240698A (cs)
KR (1) KR870008841A (cs)
CN (1) CN1031267C (cs)
AT (1) ATE102954T1 (cs)
AU (1) AU621278B2 (cs)
CA (1) CA1341064C (cs)
CS (2) CS212687A3 (cs)
DD (1) DD280765A5 (cs)
DE (2) DE3610391A1 (cs)
DK (1) DK172221B1 (cs)
EG (1) EG18175A (cs)
ES (1) ES2061447T3 (cs)
FI (1) FI91876C (cs)
HU (2) HU202118B (cs)
IE (1) IE62456B1 (cs)
MA (1) MA20919A1 (cs)
NO (1) NO178546C (cs)
NZ (1) NZ219764A (cs)
OA (1) OA08506A (cs)
PH (1) PH27210A (cs)
PT (1) PT84564B (cs)
RU (1) RU1836335C (cs)
TN (1) TNSN87045A1 (cs)
ZA (1) ZA872230B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1321753C (en) * 1987-04-27 1993-08-31 Abraham Sudilovsky Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (de) * 1987-09-16 1989-04-06 Hoechst Ag Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE3801587A1 (de) * 1988-01-21 1989-08-03 Hoechst Ag Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0331609A3 (de) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung
DE3803225A1 (de) * 1988-02-04 1989-08-17 Hoechst Ag Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US20020187977A1 (en) * 2001-03-15 2002-12-12 Rodney Pearlman Methods for restoring cognitive function following systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174844D1 (en) * 1980-10-23 1986-07-24 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3300774A1 (de) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung

Also Published As

Publication number Publication date
IE870784L (en) 1987-09-27
NZ219764A (en) 1990-11-27
EP0243645B1 (de) 1994-03-16
CS651989A3 (en) 1992-05-13
HU203117B (en) 1991-05-28
NO871282D0 (no) 1987-03-26
FI91876B (fi) 1994-05-13
MA20919A1 (fr) 1987-10-01
PT84564A (de) 1987-04-01
CN87102304A (zh) 1987-12-30
DE3789330D1 (de) 1994-04-21
FI871304A0 (fi) 1987-03-25
CS276385B6 (en) 1992-05-13
IE62456B1 (en) 1995-02-08
FI91876C (fi) 1994-08-25
DK153587D0 (da) 1987-03-26
PH27210A (en) 1993-05-04
CN1031267C (zh) 1996-03-13
NO871282L (no) 1987-09-28
DK153587A (da) 1987-09-28
OA08506A (fr) 1988-07-29
FI871304A7 (fi) 1987-09-28
CS276179B6 (en) 1992-04-15
EP0243645A2 (de) 1987-11-04
KR870008841A (ko) 1987-10-21
HUT46046A (en) 1988-09-28
AU7064987A (en) 1987-10-01
DD280765A5 (de) 1990-07-18
HU202118B (en) 1991-02-28
ZA872230B (en) 1987-09-21
DE3610391A1 (de) 1987-10-08
CS212687A3 (en) 1992-04-15
JPS62240698A (ja) 1987-10-21
ATE102954T1 (de) 1994-04-15
EP0243645A3 (en) 1990-01-24
CA1341064C (en) 2000-08-01
PT84564B (pt) 1989-11-10
HU896609D0 (en) 1990-02-28
AU621278B2 (en) 1992-03-12
TNSN87045A1 (fr) 1990-01-01
RU1836335C (ru) 1993-08-23
ES2061447T3 (es) 1994-12-16
NO178546B (no) 1996-01-08
DK172221B1 (da) 1998-01-12
EG18175A (en) 1994-07-30

Similar Documents

Publication Publication Date Title
FI862011A0 (fi) Terapeutiska nukleosider.
DE3650741D1 (de) Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
DE3482405D1 (de) Saugfaehiges wergwerferzeugnis mit vereinigten wirkstoffen zur behandlung und prophylaxe von windelausschlag und windeldermatitis.
DK463989D0 (da) Farmaceutisk virksom kombination
NO178546C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ACE-hemmere med nootrop virkning
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
FI883300A0 (fi) Menetelmä uusien terapeuttisesti aktiivisten bentsotiofeenien valmistamiseksi
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES8203086A1 (es) Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
NO881798D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
DE3687895D1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.